The Harvard Business School’s Health Care Initiative is enthusiastic to announce “The Precision Trials Challenge”. The Precision Trials Challenge is a pioneering competition to generate ideas to bring precision diagnostics and therapies to market more quickly by reinventing the clinical trials process.
The Challenge is part of a larger program funded by the Kraft Endowment for Advancing Precision Medicine, made possible by a gift from the Kraft Family Foundation, under the leadership of Foundation president Robert K. Kraft.
Pharmaceutical companies, researchers, physicians and patients share a common interest in achieving quicker diagnostics and treatments for diseases. It is essential to improve this process and bring innovative drugs to the market faster and cheaper.
Ideas from every corner of the science, medical and patient communities are welcome to step up to The Challenge. Three winners will share a $100,000 prize, gain national exposure and have an opportunity to present at the 2016 Personalized Medicine Conference.
Ideas may be submitted until evaluations begin on March 13, 2016 and the winner will be announced on April 4, 2016. To find out more, visit www.precisiontrialschallenge.org.
